We are here: Life Sciences
GVK Biosciences (GVK BIO) is one of Asia’s leading Discovery Research and Development organizations with over a decade of rich experience. GVK BIO provides a broad spectrum of services, across the R&D and manufacturing value chain with a focus on speed and quality. GVK BIO’s capabilities include Integrated Programs, Discovery Services, Development Services, Contract Manufacturing and Formulation R&D Services. With over 1700 scientists including 250 PhDs, GVK BIO caters to the research needs of more than 350 clients globally. Their portfolio comprises top 10 players globally in the fields of pharmaceutical, agrochemical, electronics, biotechnology and academics. Lower costs, superior infrastructure, boosted efficiencies and an infusion of fresh ideas make GVK BIO an ideal research partner.
GVK BIO’s world-class facilities are spread across 45 acres of land which includes chemistry labs, AAALAC accredited animal house, kilo labs and pilot plants. A match for the best globally, GVK BIO has more than 500,000 sq. ft. of dedicated laboratory space housing the most advanced and sophisticated equipment and automation. GVK BIO has been inspected by all the leading regulatory agencies of the world including USFDA, WHO, KFDA, PMDA, EDQM, EMEA and DCGI, India.
Headquartered in Hyderabad, GVK BIO also has operational facilities in Bangalore and California providing customers with a flexible range of services and business models. In January, 2014 GVK BIO acquired Aragen Bioscience, Inc., a privately held US-based preclinical CRO specializing in high value biologics services, thereby positioning GVK BIO as a leading provider of integrated R&D services across both large and small molecule platforms. With a compelling value proposition, GVK BIO continues to be the partner of choice for its loyal and increasing customer base.